nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—forelimb—amyotrophic lateral sclerosis	0.224	0.317	CbGeAlD
Ximelagatran—F2—hindlimb—amyotrophic lateral sclerosis	0.202	0.285	CbGeAlD
Ximelagatran—F2—appendage—amyotrophic lateral sclerosis	0.173	0.245	CbGeAlD
Ximelagatran—F2—Regulation of IGF Activity by IGFBP—IGFALS—amyotrophic lateral sclerosis	0.0791	0.269	CbGpPWpGaD
Ximelagatran—F2—spinal cord—amyotrophic lateral sclerosis	0.0327	0.0463	CbGeAlD
Ximelagatran—F2—nervous system—amyotrophic lateral sclerosis	0.0276	0.039	CbGeAlD
Ximelagatran—F2—central nervous system—amyotrophic lateral sclerosis	0.0265	0.0376	CbGeAlD
Ximelagatran—F2—brain—amyotrophic lateral sclerosis	0.0211	0.0298	CbGeAlD
Ximelagatran—F2—Regulation of IGF Activity by IGFBP—IGFBP3—amyotrophic lateral sclerosis	0.0198	0.0673	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—C5AR1—amyotrophic lateral sclerosis	0.0109	0.0371	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.0105	0.0356	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00964	0.0328	CbGpPWpGaD
Ximelagatran—F2—Regulation of IGF Activity by IGFBP—IGF1—amyotrophic lateral sclerosis	0.00836	0.0285	CbGpPWpGaD
Ximelagatran—F2—Post-translational protein modification—PIGW—amyotrophic lateral sclerosis	0.0078	0.0265	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00696	0.0237	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.00674	0.0229	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.00592	0.0201	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.00549	0.0187	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—MMP9—amyotrophic lateral sclerosis	0.00547	0.0186	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.00498	0.0169	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00488	0.0166	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.00479	0.0163	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—C3—amyotrophic lateral sclerosis	0.00476	0.0162	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.00436	0.0148	CbGpPWpGaD
Ximelagatran—F2—Syndecan-4-mediated signaling events—MMP9—amyotrophic lateral sclerosis	0.00434	0.0148	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.00432	0.0147	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.00428	0.0146	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.0037	0.0126	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00356	0.0121	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00338	0.0115	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00287	0.00976	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.0028	0.00954	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00247	0.00841	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00231	0.00786	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.0023	0.00782	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00222	0.00757	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.0022	0.0075	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00218	0.00743	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00209	0.0071	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.002	0.00679	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00194	0.00661	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00187	0.00637	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00187	0.00635	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00181	0.00615	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00165	0.00562	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.00165	0.00562	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00139	0.00473	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.00127	0.00433	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00127	0.00433	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00125	0.00426	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00123	0.0042	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.00122	0.00415	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00118	0.00402	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00113	0.00383	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00112	0.00381	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00111	0.00378	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.00108	0.00366	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000965	0.00328	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000953	0.00324	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000874	0.00297	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000831	0.00283	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000821	0.0028	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000808	0.00275	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000797	0.00271	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000779	0.00265	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000762	0.00259	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000754	0.00257	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00067	0.00228	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000662	0.00225	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000656	0.00223	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000619	0.00211	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000619	0.00211	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000577	0.00197	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000566	0.00193	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000554	0.00188	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000539	0.00183	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000527	0.00179	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000516	0.00176	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000495	0.00168	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000489	0.00166	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000455	0.00155	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000448	0.00152	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000428	0.00146	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000427	0.00145	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000406	0.00138	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000348	0.00118	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000339	0.00115	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000327	0.00111	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000324	0.0011	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000313	0.00107	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000289	0.000984	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000285	0.000971	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000269	0.000916	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000257	0.000875	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000235	0.000799	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000222	0.000757	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000171	0.000582	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000162	0.00055	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000161	0.000547	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000145	0.000494	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000138	0.00047	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000127	0.000432	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.00011	0.000373	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	0.000105	0.000356	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.16e-05	0.000244	CbGpPWpGaD
